Total medical devices industry deals worth $5.7bn were announced globally for August 2022, with Bain Capital’s $3.12bn private equity deal with Evident being the sector’s biggest investment, according to GlobalData’s deals database.
Go deeper with GlobalData
- Embed this chart
Embed this chart into your website
Copy and paste the image source into your website to display the chart.
The value marked a decrease of 39.5% over the previous month of $9.36bn and a drop of 54.7% when compared with the last 12-month average of $12.48bn.
In terms of number of deals, the sector saw a drop of 21.89% with 157 deals in August 2022 when compared to the last 12-month average of 201 deals.
In value terms, Asia-Pacific led the activity with deals worth $3.35bn in August 2022.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalDataMedical Devices industry deals in August 2022: Top deals
The top five deals accounted for 76.2% of the overall value during August 2022.
The combined value of the top five deals stood at $4.31bn, against the overall value of $5.7bn recorded for the month.
The top five medical devices industry deals of August 2022 tracked by GlobalData were:
1) Bain Capital’s $3.12bn private equity deal with Evident
2) The $468.22m acquisition of B Medical Systems by Azenta
3) Teleflex’s $300m acquisition deal with Standard Bariatrics
4) The $250m acquisition of Biorez by ConMed
5) Bio-Rad Laboratories’s $170m acquisition deal with Curiosity Diagnostics
